薬学部
Ohara H, Odanaka K, Shiine M, Hayasaka M. Antimicrobial Effect of Oral Care Gel-Containing Hinokitiol and 4-isopropyl-3-methylphenol Against Intraoral Pathogenic Microorganisms. (2023) PLOSONE. 18(9): e0283295. doi: 10.1371/journal.pone.0283295.
Odanaka K. Mizoribine is effective against Leclercia adecarboxylata infection. (2022) Int J Pharm Sci Res. 13(11): 4455-4458.
Nakagawa N, Odanaka K, Ohara H, Kisara S. Communication training for pharmacy students with standard patients using artificial intelligence. (2022) Curr Pharm Teach Learn. 14(7): 854-862.
Odanaka K. Identification of a Candida albicans biofilm inhibitor. (2022) Am J Mol Biol. 12: 23-29.
Nakagawa N, Odanaka K, Ohara H, Ito T, Kisara S, Ito K. Effect of smartphone location on pharmacy students’ attention and working memory. (2022) J Adv Pharm Edu Res. 2022;12(2): 84-90.
Nakagawa N, Odanaka K, Ohara H, Kisara S. Evaluation of drug information literacy gained through e-learning to prepare students for practical pharmacy experience. (2021) J Adv Pharm Edu Res. 1(4): 111-115.
Odanaka K, Kojima H, Nakagawa N. Study on the Optimal Conditions for Long-term Storage of Melatonin Powder as an In-hospital Preparation. (2021) Int J Pharm Comd. 25(3): 258-262.
Odanaka K, Watanabe M. New candidate antigens for serodiagnosis of pertussis. (2018) Ann Biomed Res. Vol1(1): 1-6.
Odanaka K, Iwatsuki M, Satho T, Watanabe M. Identification and characterization of a yellow pigment produced by Bordetella pertussis. (2017) Microbiol Immunol. 61(11): 490-496.
Saito M, Odanaka K, Otsuka N, Kamachi K, Watanabe M. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model. (2016) Microbiol Immunol. 60(9): 599-608.